PROCEPT BioRobotics is a medical technology company specializing in minimally invasive surgical solutions for urological conditions, focusing on Benign Prostatic Hyperplasia (BPH) treatment. The company has developed the Aquablation therapy, which uses a computer-assisted, ultrasound-guided robotic system to deliver precise and personalized treatment without compromising sexual function and continence. Their technology platform is powered by robotics and artificial intelligence to maximize tissue resection while preserving important anatomy. PROCEPT BioRobotics is committed to advancing men's health with proven, precise, and predictable treatments.